Michael Gaffin

🏛️ Revolving Door

Former Government Positions:

Leg. Director, Sen. Sherrod Brown; Leg. Director, Rep. Rob Andrews; Leg. Asst., Rep. Anna Eshoo; Jr. Leg. Assoc., House Ed. and Labor Committee, Rep. George Miller; Staff Asst., Senate HELP Committee, Sen. Edward Kennedy

Monitored S.2210, to amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes.

Share:𝕏LinkedInFacebook
🤖

AI Overview

Michael Gaffin has appeared in 599 federal lobbying filings at The Smith-free Group, LLC, representing 34 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 37 policy areas.

599
Total Filings
1
Firms
34
Clients
37
Issue Areas

Issue Areas

NATENVLBRHCRMMMBANCIVFINCSPTAXEDUTRDTOBRRRENGINSBUDSMBFOOMEDTRATOUHOUIMMAGRCPTARTLAWDEFHOMVETAVIMIAFORPHATARCOM

Filing History

YearFilingsClients
20219020
202213819
202312917
20249915
202514316

Firms

The Smith-free Group, LLC599 filings

Top Clients

The Kroger Co.101 filings
Universal Corporation85 filings
HCA66 filings
Rai Services Company50 filings
Rescare INC (DBA Brightspring Health Services)35 filings
American Dental Association33 filings
Csx Corporation27 filings
Sidecar Health, INC25 filings
American Hospital Association19 filings
Mastercard Worldwide16 filings
Rio Tinto Services INC.13 filings
Housing Policy Council11 filings
Sony Pictures Entertainment11 filings
Wcg Clinical, INC.10 filings
Teva Pharmaceuticals USA, INC.9 filings
Walker & Dunlop INC.9 filings
Pillar Health Group9 filings
Comstock & Holt, INC.9 filings
Gvb Biopharma8 filings
National Propane Gas Association8 filings

Related Analysis

🏛️ Revolving Door Premium
Do ex-government lobbyists earn more?
🕸️ Network Analysis
Explore connections between firms and lobbyists
🎯 Market Concentration
How concentrated is the lobbying market?

Related Investigations

The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Follow the Money
Tracking lobbying dollars through the financial system.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.

Explore More

← All Lobbyists🏛️ Revolving Door🕸️ Network Analysis🏛️ Agency Pressure 🔍 Investigations

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.